ArticleAlzheimer's & dementia (New York, N. Y.)

Clinical efficacy of anti-amyloid antibodies in apolipoprotein E ε4 homozygotes: A Bayesian reanalysis of lecanemab and donanemab phase 3 results.

Stefan Teipel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.